MARATTO

article · PLoS ONE

Will Africans take COVID-19 vaccination?

202194 citationsOpen accessUniversité de Kinshasa (UNIKIN)

In plain language

A survey of 5,416 Africans across 34 countries and the diaspora assessed willingness to receive COVID-19 vaccines alongside key determinants of hesitancy. Overall, 63 percent of respondents expressed willingness to receive a vaccine as soon as possible, but 79 percent reported concerns regarding side effects and 39 percent feared vaccine-associated infection. Risk perception significantly influenced attitudes: individuals who believed they faced a very high risk of infection or severe illness had markedly lower odds of hesitancy. In contrast, individuals who had previously refused a vaccine for themselves or their child had more than two and a half times higher odds of hesitancy. Most participants preferred vaccines to be provided free of charge, while substantial numbers favoured workplace or home distribution and mandatory policies.

Key takeaways

  • Only 63 percent of surveyed participants were willing to receive a COVID-19 vaccine as soon as possible.
  • Concerns about safety were prevalent, with 79 percent worried about side effects and 39 percent concerned about vaccine-associated infection.
  • Higher perceived risk of infection or severe illness was linked to significantly lower odds of vaccine hesitancy.
  • A self-reported history of refusing vaccines was associated with an increase in the odds of hesitancy.
  • Most respondents favoured free vaccine provision, with additional support for home or office delivery and mandatory vaccination.

Why it matters

Understanding public attitudes towards immunization is essential for designing effective disease control strategies. The findings show that vaccine hesitancy in Africa is strongly shaped by perceived individual risk, prior vaccination behaviour, and fears about safety. Recognising these factors helps health authorities tailor communication and design delivery models that address specific community concerns and logistical preferences.

Commercialisation angle

The abstract does not indicate an application pathway.

AI-generated from the published abstract. Always read the original work before citing.

Abstract

The economic and humanistic impact of COVID-19 pandemic is enormous globally. No definitive treatment exists, hence accelerated development and approval of COVID-19 vaccines, offers a unique opportunity for COVID-19 prevention and control. Vaccine hesitancy may limit the success of vaccine distribution in Africa, therefore we assessed the potentials for coronavirus vaccine hesitancy and its determinants among Africans. An online cross-sectional African-wide survey was administered in Arabic, English, and French languages. Questions on demographics, self-reported health status, vaccine literacy, knowledge and perception on vaccines, past experience, behavior, infection risk, willingness to receive and affordability of the SARS-COV-2 vaccine were asked. Data were subjected to descriptive and inferential statistics. A total of 5,416 individuals completed the survey. Approximately, 94% were residents of 34 African countries while the other Africans live in the Diaspora. Only 63% of all participants surveyed were willing to receive the COVID-19 vaccination as soon as possible and 79% were worried about its side effects. Thirty-nine percent expressed concerns of vaccine-associated infection. The odds of vaccine hesitancy was 0.28 (95% CI: 0.22, 0.30) among those who believed their risk of infection was very high, compared to those who believed otherwise. The odds of vaccine hesitancy was one-fifth (OR = 0.21, 95% CI: 0.16, 0.28) among those who believed their risk of falling sick was very high, compared to those who believed their risk of falling very sick was very low. The OR of vaccine hesitancy was 2.72 (95% CI: 2.24, 3.31) among those who have previously refused a vaccine for themselves or their child compared to counterparts with no self-reported history of vaccine hesitancy. Participants want the vaccines to be mandatory (40%), provided free of charge (78%) and distributed in homes and offices (44%). COVID-19 vaccine hesitancy is substantial among Africans based on perceived risk of coronavirus infection and past experiences.

Research topics

  • Vaccine Coverage and Hesitancy
  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 epidemiological studies

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1371/journal.pone.0260575

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.